Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?

To: crysball who wrote (1279)	9/23/1998 11:15:00 PM
From: Ariella	Read Replies (1) \| Respond to of 1491

Neil ...great idea. Hope you won't be surprised to hear that I've done some recently. Have not posted the actual targets of my e-mail since we need to avoid the deluge of mail to a particular source -- as happened with the Washington Post -- that ends up boomeranging on the company. Too much mail looks like hype and ruins a well-intentioned communication. Please also be aware that the company is NOT asleep at the switch on this one. I recently forwarded a list of Wall Street all-star analysts and they already had the folks on their rolodex. On the other hand, I've got huge lists of people in the trauma/neurology field who might take a request for information e-mail that at the same time brings the trial results to their attention. If anyone wants to take a "piece" of the list, let me know. ;-) Ariella P.S. It's also a good idea to keep the address of anyone to whom you write. When HU-211 news comes out, if good, mail them again....